Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma.
about
Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patientsThe use of therapeutic peptides to target and to kill cancer cells.The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach.Tumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapy.Hemorrhagic events in hepatocellular carcinoma patients treated with antiangiogenic therapies.Targeting of the innate immunity/inflammation as complementary anti-tumor therapies.Tumour vasculature targeting agents in hybrid/conjugate drugs.Peptide-mediated targeting of cytokines to tumor vasculature: the NGR-hTNF example.Second line systemic therapy options for advanced hepatocellular carcinoma; a systematic review.Enhanced expression of CD13 in vessels of inflammatory and neoplastic tissues.A model for cancer-suppressive inflammationThe tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms.
P2860
Q24633820-0A73F0E3-A883-43C2-99E9-2D0C4E922606Q30418414-2753A0DE-884E-4DED-AE7A-D701180B26CCQ33683970-34AEC5F3-2F08-48C0-977D-2948CB62E785Q35974293-B8C812C6-1D6C-47D9-BED9-760C1321CCAFQ36644408-00FBF64A-E82F-4A2C-8191-9AB1E1C76F07Q37901025-AF76D71A-0B79-4FDF-A79F-FE2E5D6D7BF4Q38094627-58936E90-7752-4682-AC17-9097A5CF4575Q38112578-44C75FEC-3390-4377-AA33-03335FE132E6Q38264330-B13FF6D9-FC96-403D-87DC-5402368A0A41Q38819807-04A27734-B7D7-42DD-B9F5-B91635E203D7Q41275639-DBF04300-11BE-4C9C-A1CE-419DAF52A4D4Q41577994-2EF326C2-2626-4030-AE1D-C543E03DBA00
P2860
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Activity and safety of NGR-hTN ...... nced hepatocellular carcinoma.
@ast
Activity and safety of NGR-hTN ...... nced hepatocellular carcinoma.
@en
Activity and safety of NGR-hTN ...... nced hepatocellular carcinoma.
@nl
type
label
Activity and safety of NGR-hTN ...... nced hepatocellular carcinoma.
@ast
Activity and safety of NGR-hTN ...... nced hepatocellular carcinoma.
@en
Activity and safety of NGR-hTN ...... nced hepatocellular carcinoma.
@nl
prefLabel
Activity and safety of NGR-hTN ...... nced hepatocellular carcinoma.
@ast
Activity and safety of NGR-hTN ...... nced hepatocellular carcinoma.
@en
Activity and safety of NGR-hTN ...... nced hepatocellular carcinoma.
@nl
P2093
P2860
P50
P356
P1476
Activity and safety of NGR-hTN ...... anced hepatocellular carcinoma
@en
P2093
A Lambiase
C Bordignon
F Caligaris-Cappio
G Citterio
G Donadoni
S Bozzarelli
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605858
P407
P577
2010-08-17T00:00:00Z
P5875
P6179
1032128939